Dosdos, Rogelio M.
HRN: 23-78-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/29/2023
10/06/2023
IV
1.5grams
Q6hrs
DM Foot, Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes